Martin Bernert

发表

Patented therapeutic approaches targeting LRP/LR for cancer treatment

Eloise Ferreira, Stefan F. T. Weiss, Elvira Singh, 2019, Expert opinion on therapeutic patents.

Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity

M. Little, U. Reusch, Eloise Ferreira, 2015, PloS one.

37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers in vitro

Eloise Ferreira, Stefan F. T. Weiss, S. Weiss, 2017, Oncotarget.

Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells

Eloise Ferreira, Stefan F. T. Weiss, Monique J. Bignoux, 2022, FEBS open bio.

Investigating telomere dynamics in oesophageal squamous carcinoma cells using standard and gold nanoparticle-based assays

Martin Bernert, 2017 .